An ethical and socially responsible company
Boehringer Ingelheim works to discover and develop innovative, safe and effective ways to treat and prevent some of the world's most challenging diseases. As a world-leading innovative pharmaceutical company, we boast a large and experienced global team who manage and conduct clinical trials in a broad range of indications.
The safety of participants who take part in each of our clinical trials is of the utmost importance and we are commited to upholding the highest international standards in all of our research initiatives.
In Australia and New Zealand
Boehringer Ingelheim adheres to a range of worldwide standards in conducting clinical trials. The most important of these is the Note for guidance on Good Clinical Practice (ICH GCP), an international ethical and scientific quality standard for designing, conducting, recording, monitoring and reporting clinical trials.
By adhering to the standards set out in ICH GCP, Boehringer Ingelheim ensures that the rights of patients are protected, their safety and well-being is assured and the validity and integrity of our scientific data is unquestionable.
